Israel’s ODE Pharma has discovered that a molecule, code named ODE-001 and derived from the papaya fruit, reduces inflammation and deterioration in organs adversely affected by cystic fibrosis. One scientist who originally suggested the molecule is Nobel laureate Aaron Ciechanover.
https://nocamels.com/2024/08/startup-sees-potential-of-papaya-to-treat-cystic-fibrosis-in-kids/